Literature DB >> 17570263

Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.

Mariana Toscani1, Raphaella Migliavacca, José Augusto Sisson de Castro, Poli Mara Spritzer.   

Abstract

Insulin resistance (IR) is an independent risk factor for cardiovascular disease and is a prevalent metabolic disturbance among women with polycystic ovary syndrome (PCOS). Central adiposity, a marker of IR and an accurate anthropometric method to estimate truncal adiposity, may represent a key clinical tool for IR screening in subpopulations at higher metabolic and cardiovascular risk, such as women with PCOS. The aims of the present study were (1) to investigate the influence of androgens on IR and central obesity in overweight or obese hirsute women with or without PCOS and (2) to test the reliability of the sum of trunk skinfolds (subscapular, suprailiac, and abdominal) to estimate truncal adiposity. This observational, cross-sectional study included 37 hirsute patients with body mass index of 25 kg/m(2) or greater and aged between 14 and 41 years. Twenty-four had PCOS, and 13 had ovulatory cycles, normal androgen levels, and isolated hirsutism, named idiopathic hirsutism (IH). Nutritional, anthropometric, clinical, and laboratory evaluations were performed. Body composition was assessed by measurement of waist circumference and skinfold thickness and by dual-energy x-ray absorptiometry (DXA). Both groups presented similar ages, body mass index, and hirsutism score. The PCOS group had higher androgen levels, homeostasis model assessment (HOMA) index, and fasting insulin levels. Free androgen index was positively associated with HOMA, independent of truncal adiposity (r = 0.441, P = .009). Strong correlations were also observed between truncal adiposity measured by DXA and both the sum of trunk skinfolds (r = 0.863, P = .0001) and waist circumference in hirsute patients (r = 0.947, P = .0001). In our study, IR (HOMA index >/=3.8) was associated with truncal obesity, with a more androgenic profile, and with an unfavorable lipid profile. In conclusion, hirsutism per se appears not to be a risk for IR and related cardiovascular disease unless there is presence of central adiposity and/or abnormal androgen profile as observed in patients with PCOS. Waist circumference and the sum of trunk skinfolds represent accurate methods to estimate truncal adiposity, but waist circumference measurement seems to be the simplest method of clinical screening for IR in hirsute women.

Entities:  

Mesh:

Year:  2007        PMID: 17570263     DOI: 10.1016/j.metabol.2007.03.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Haplotype TGTG from SNP 45T/G and 276G/T of the adiponectin gene contributes to risk of polycystic ovary syndrome.

Authors:  S Radavelli-Bagatini; I O de Oliveira; R B Ramos; B R Santos; M S Wagner; S B Lecke; D P Gigante; B L Horta; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

2.  Androgenicity and venous endothelial function in post-menopausal women.

Authors:  M A Maturana; M C Rubira; F Consolim-Colombo; M C Irigoyen; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

3.  A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances.

Authors:  F Ramezani Tehrani; S Behboudi-Gandevani; M Simbar; F Azizi
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

4.  Single nucleotide polymorphisms in binding site of miRNA-135a and targeted gene IRS2 are correlated with multiple clinical features of PCOS: A study in Chinese women.

Authors:  Heng Gu; Longyu Li; Bingyi Zhou; Mingzhen Li; Wenyao Zhong; Xiangcai Wei; Xingmin Zhong
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

5.  Autonomic dysfunction in women with polycystic ovary syndrome.

Authors:  Zainab Hasan Hashim; Farqad Bader Hamdan; Anam Rashid Al-Salihi
Journal:  Iran J Reprod Med       Date:  2015-01

6.  Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.

Authors:  Betânia Rodrigues Santos; Sheila Bünecker Lecke; Poli Mara Spritzer
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

7.  Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study.

Authors:  Betânia Rodrigues Santos; Sheila Bunecker Lecke; Poli Mara Spritzer
Journal:  Reprod Biol Endocrinol       Date:  2018-04-18       Impact factor: 5.211

8.  c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals.

Authors:  Karly C Sourris; Jasmine G Lyons; Maximilian P J de Courten; Sonia L Dougherty; Darren C Henstridge; Mark E Cooper; Michelle Hage; Anthony Dart; Bronwyn A Kingwell; Josephine M Forbes; Barbora de Courten
Journal:  Diabetes       Date:  2009-03-03       Impact factor: 9.461

9.  Circulating levels and subcutaneous adipose tissue gene expression of pigment epithelium-derived factor in polycystic ovary syndrome and normal women: a case control study.

Authors:  Sheila B Lecke; Debora Morsch; Poli M Spritzer
Journal:  Reprod Biol Endocrinol       Date:  2013-08-14       Impact factor: 5.211

10.  Imaging-Based Body Fat Distribution in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Shiqin Zhu; Zeyan Li; Cuiping Hu; Fengxuan Sun; Chunling Wang; Haitao Yuan; Yan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.